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Background: Gestational diabetes (GDM) has been shown to have long-term sequelae for both the mother and
infant. Women with GDM are at increased risk of macrosomia, which predisposes the infant to birth injuries.
Previous studies noted increased rates of GDM in Asian and Pacific Islander (API) women; however, the rate of
macrosomia in API women with GDM is unclear. The objective of this study was to examine the relationship
between ethnicity, gestational diabetes (GDM), and macrosomia in Hawaii.
Methods: A retrospective cohort study was performed using Hawaii Pregnancy Risk Assessment Monitoring System
(PRAMS) data. Data from 2009–2011, linked with selected items from birth certificates, were used to examine GDM
and macrosomia by ethnicity. SAS-callable SUDAAN 10.0 was used to generate odds ratios, point estimates and
standard errors.
Results: Data from 4735 respondents were weighted to represent all pregnancies resulting in live births in Hawaii
from 2009–2011. The overall prevalence of GDM in Hawaii was 10.9%. The highest prevalence of GDM was in
Filipina (13.1%) and Hawaiian/Pacific Islander (12.1%) women. The lowest prevalence was in white women (7.4%).
Hawaiian/Pacific Islander, Filipina, and other Asian women all had an increased risk of GDM compared to white
women using bivariate analysis. Adjusting for obesity, age, maternal nativity, and smoking, Asian Pacific Islander
(API) women, which includes Hawaiian/Pacific Islander, Filipina, and other Asian women, had a 50% increased odds
of having GDM compared to white women when compared using multivariate analysis. Among women with GDM,
the highest prevalence of macrosomia was in white women (14.5%) while the lowest was in Filipina (5.3%) women.
Conclusions: API women in Hawaii have increased rates of GDM compared to white women. Paradoxically, this
elevated GDM risk in API women is not associated with an increased rate of macrosomia. This suggests the
relationship between GDM and macrosomia is more complex in this population.
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Gestational diabetes (GDM), defined as any degree of
glucose intolerance with onset or first recognition during
pregnancy, complicates approximately 7% of all pregnan-
cies, resulting in more than 200,000 cases annually [1].
In the past decade, the overall incidence of GDM
significantly increased even after adjusting for age and
ethnicity [2]. GDM has been associated with adverse preg-
nancy outcomes, such as macrosomia, [3] birth trauma, [4]
shoulder dystocia, [5] cesarean section, [3,6] pre-eclampsia,
[7] preterm birth, [8] neonatal hypoglycemia, [3,4] and* Correspondence: paijong@hawaii.edu
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reproduction in any medium, provided the orneonatal hyperbilrubinemia [4]. GDM predisposes
women to a 3-fold increased risk of having infants with
macrosomia, [9] which is an important risk factor for
shoulder dystocia, [10,11] brachial plexus injury,
[11,12] and perinatal mortality [12]. Women with
macrosomic infants are at increased risk of cesarean
section, hemorrhage, and perineal trauma [11].
Racial/ethnic differences in GDM have been noted in
previous studies [13] and Asian and Pacific Islander
(API) women were consistently shown to have the
highest rates, ranging from 6 to 16%. A retrospective co-
hort study using birth certificate data in California noted
GDM prevalence to be 10% among Asian women, higher
than white (4.6%), Black (4.5%), and Hispanic (6.9%). This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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had a 50 percent increased risk of GDM compared to
white women [15]. Another study using birth certificate
data in the U.S. showed API women had a substantially
higher age-adjusted prevalence of GDM (6.3%) com-
pared to white (3.8%), Black (3.5%), or Hispanic (3.6%)
women. They also noted significant differences among
API subgroups, ranging from 3.7% in Japanese women
to 8.6% in Asian Indian women [16]. A study using
self-reported data in Oregon noted non-Hispanic API
women have the highest rates of GDM (14.8%) com-
pared to Hispanic (11.1%), non-Hispanic Black (8.1%),
non-Hispanic American Indian women (7.9%), and non-
Hispanic Whites (6.0%). Within the API group, they
found that Asian women had a higher prevalence of GDM
(16.4%) compared to Pacific Islander women (11.7%) [17].
Using birth certificate data in New York, Chinese and
non-Chinese East Asian/Pacific Islander women were
found to have increased odds of GDM, OR 1.9 (95% CI 1.8-
2.1) and 1.7 (95% CI 1.5-1.8), respectively, compared to
white women [18].
Although studies clearly illustrated the increased risk
of GDM in API women, perinatal outcomes associated
with GDM, such as macrosomia, in API women are
unclear.
Two studies showed a decreased risk of adverse
perinatal outcomes in Asian women with GDM. Nguyen
et al. [14] noted Asian women had lower odds of
macrosomia, pre-eclampsia, cesarean section, neonatal
hypoglycemia, and RDS when compared to white, black,
and Hispanic women. Esakoff et al. [19] also noted de-
creased risk of macrosomia and cesarean section in
Asian women with GDM compared to white women. In
a hospital-based cohort of women with GDM, Silva et al.
[20] noted an increased prevalence of macrosomia in
neonates born to Hawaiians/Pacific Islander and Filipino
women compared to neonates of Japanese, Chinese,
Caucasian women.
Given this background, the objective of this study was
to examine the relationship between ethnicity, particu-
larly among Asians and Pacific Islanders, and the rates
of gestational diabetes and macrosomia from a popula-
tion perspective in Hawaii.
Methods
This study was approved by the Western Institutional
Review Board (IRB), the IRB of the Human Research
Protection Office of the Centers for Disease Control and
Prevention, and the State of Hawaii, Department of Health
IRB. This study was conducted using Hawaii Pregnancy
Risk Assessment Monitoring System (PRAMS) data from
2009 to 2011. PRAMS is a self-reported survey of recent
mothers designed to collect information on maternal be-
haviors, attitudes, and experiences before, during, andimmediately after pregnancy. PRAMS is a collaborative ef-
fort of the Centers for Disease Control and Prevention
(CDC) and state health departments. Currently 40 states
and New York City participate in the PRAMS program,
representing 78% of all live births in the country. The
PRAMS program uses a standardized data collection proto-
col including a mailed questionnaire (self-administered)
with telephone follow-up for non-responders. Approxi-
mately 2,400 mothers a year in Hawaii are selected for
participation as part of a stratified sample drawn from the
certificates of live birth in Hawaii. Women complete
the survey 3–9 months postpartum, with the majority
responding at 3–4 months postpartum. The Hawaii
PRAMS dataset includes information collected from
PRAMS survey questions and from selected linked birth
certificate variables. Data are weighted on an annual basis
according to CDC protocol to be representative of all preg-
nancies resulting in live births in Hawaii in a given year.
States must achieve a minimum response rate of 65% in
order for survey results to be considered generalizable to all
live births in the state in a given year. Hawaii PRAMS an-
nual response rates have not fallen below 70% since data
collection began in 2000, and the response rates for the
years presented in this analysis ranged from 71-73%.
The following question from the PRAMS survey
pertaining to gestational diabetes was used for this ana-
lysis: “During your most recent pregnancy, were you told
by a doctor, nurse, or other health care worker that you
had gestational diabetes (diabetes that started during this
pregnancy)?” The independent variables included mater-
nal age, maternal race/ethnicity, maternal pre-pregnancy
body mass index (BMI), maternal nativity, household in-
come, maternal education, marital status, smoking in the
last 3 months of pregnancy, and presence of first trimes-
ter prenatal care. The dependent variables included pres-
ence of gestational diabetes and macrosomia (birth
weight greater than 4000 grams) among women with
gestational diabetes. Birth weight, along with maternal
age, race/ethnicity, nativity, education, and marital status
were determined based on linked birth certificate vari-
ables included in the Hawaii PRAMS dataset. Maternal
race/ethnicity variables have been sorted into singly-
coded groups using a standard algorithm used by the
Hawaii Department of Health, Office of Health Status
and Monitoring (OHSM) [21]. Maternal pre-pregnancy
BMI, household income, smoking in the last 3 months
of pregnancy, and presence of first trimester prenatal
care were determined based on self-reported informa-
tion in the Hawaii PRAMS survey.
Prevalence estimates and confidence intervals were gen-
erated for GDM and macrosomia using SAS-callable
SUDAAN 10.0 to account for PRAMS’ complex sampling
design. Descriptive statistics were generated to compare
demographic information, including age, ethnicity, pre-
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ternal education, marital status, smoking status, and first
trimester prenatal care. For examining GDM rates, bivariate
analysis was performed to identify potential confounders at
p < 0.10. Multivariate logistic regression using forward se-
lection was then performed to examine GDM and maternal
ethnicity with whites as the referent group, controlling for
BMI, age, maternal nativity, and smoking. Smoking was not
significantly associated with GDM and maternal ethnicity,
thus, was excluded from the final model. The final model
adjusted for maternal age, BMI, and maternal nativity. Bi-
variate analysis was also used to examine the association
between macrosomia and ethnicity in women with GDM.
Due to limited cases of macrosomia in women with
GDM by ethnicity, multivariate analysis was unable to be
performed.
Results
A total of 4735 participants that were weighted to repre-
sent all pregnancies resulting in live birth in Hawaii fromTable 1 Maternal characteristics by ethnicity, expressed in pr
Maternal characteristics White N (%) Hawaiian/PIa N (%
Maternal age (yrs)
< 25 3340 (26.1) 9174 (44.0)
≥ 25 9473 (73.9) 11677 (56.0)
BMI
Underweight/Normal 8243 (66.2) 9754 (49.1)
Overweight/Obese 4217 (33.8) 10107 (50.9)
Maternal nativity
US born 11274 (88.0) 17316 (83.1)
Foreign born 1540 (12.0) 3535 (17.0)
Household income
< $10,000 703 (5.8) 6543 (33.7)
$10,000-49,999 5791 (47.9) 8774 (45.2)
≥ $50,000 5586 (46.2) 4098 (21.1)
Maternal education
High school or less 4665 (36.7) 13621 (66.8)
Some college 8037 (63.3) 6758 (33.2)
Married
No 2343 (18.3) 12360 (59.3)
Yes 10470 (81.7) 8492 (40.7)
Smoking last 3 months of pregnancy
No 11936 (94.7) 18223 (88.9)
Yes 669 (5.3) 2272 (11.1)
1 trimester prenatal care
No 1253 (10.0) 4908 (23.9)
Yes 11347 (90.0) 15664 (76.1)
aIncludes Samoan, Guamanian, Other Pacific Islanders.
bIncludes Japanese, Chinese, Korean, Vietnamese, Asian Indian, and other Asians.2009–2011 were evaluated. This cohort consisted of
22.8% white women, 38.1% Hawaiian/Pacific Islander
women, 19.0% Filipina, and 14.9% other Asian women.
Pacific Islander women included Samoan, Guamanian,
and other Pacific Islanders. Other Asian women in-
cluded Japanese, Chinese, Korean, Vietnamese, Asian
Indian, and other Asian women. The breakdown of these
groups was chosen based on their similarities with
regards to other health outcomes observed in our popu-
lation. The majority of participants received prenatal
care in the first trimester of pregnancy and were above
25 years of age, of normal pre-pregnancy BMI, born in
the U.S., college educated, married, and non-smokers in
last 3 months of pregnancy. Maternal characteristics dif-
fered significantly by ethnicity (Table 1). Other Asian
women had the highest percentage of advanced maternal
age (33.8%) while Hawaiian/Pacific Islander women had
the highest percentage of births to teens (12.5%). The
highest prevalence of pre-pregnancy obesity was in
Hawaiian/Pacific Islander women (23.8%), while the lowestevalence
) Filipina N (%) Other Asiansb N (%) P-value
2667 (26.9) 1082 (11.7) < 0.01
7255 (73.1) 8143 (88.3)
5958 (63.0) 6554 (74.3) < 0.01
3506 (37.1) 2268 (25.7)
4775 (48.1) 5945 (64.8) < 0.01
5147 (51.9) 3224 (35.2)
1541 (16.9) 755 (8.6) < 0.01
4508 (49.5) 3037 (34.6)
3067 (33.7) 4996 (56.9)
3983 (40.8) 2254 (24.8) < 0.01
5769 (59.2) 6839 (75.2)
4127 (41.6) 1832 (19.9) < 0.01
5795 (58.4) 7393 (80.1)
9378 (95.7) 8552 (94.3) < 0.01
427 (4.3) 518 (5.7)
1457 (15.0) 863 (9.4) < 0.01
8228 (85.0) 8289 (90.6)
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pinas were foreign-born. Hawaiian/Pacific Islander women
had the highest prevalence of smoking in the last 3 months
of pregnancy (11.1%), while the lowest was observed in Fili-
pina women (4.3%).
The overall prevalence of GDM in Hawaii was 10.9%.
GDM prevalence varied significantly by ethnicity, mater-
nal age, BMI, nativity, and smoking in the last 3 months
of pregnancy (Table 2). The increase in GDM was linearTable 2 Maternal characteristics of women with GDM
Maternal characteristics GDM (%) GDM weighted
Total sample 10.9 5925
Maternal ethnicity
White 7.4 934
Hawaiian/Pacific Islandera 12.1 2450
Filipina 13.1 1258
Other Asiansb 11.0 989
White 7.4 934
Asian Pacific Islanderc 12.1 4697
Maternal age (yrs)
< 25 6.9 1154
≥ 25 12.8 4802
BMI
Underweight/Normal 6.8 2127
Overweight /Obese 16.7 3474
Maternal nativity
US born 9.8 3972
Foreign born 14.7 1985
Household income
< $10,000 9.5 913
$10,000-49,999 11.6 2664
≥ $50,000 11.2 2050
Maternal education
High school or less 11.6 2908




Smoking last 3 month of pregnancy
No 10.6 5330
Yes 15.3 620
1st trimester prenatal care
No 12.9 1122
Yes 10.5 4712
aIncludes Samoan, Guamanian, Other Pacific Islanders.
bIncludes Japanese, Chinese, Korean, Vietnamese, Asian Indian, and other Asians.
cIncludes Hawaiians, Other Pacific Islanders, Filipinos, and Other Asians.
dData significance at p-value < 0.05.by maternal age for all ethnicities. Prevalence of GDM
among women under 20 years of age was 4.6% while
women above age 35 had a prevalence of 17.4%. The
highest prevalence was in Filipina (13.1%) and Hawaiian/
Pacific Islander (12.1%) women, while the lowest was
in white women (7.4%). GDM prevalence was higher in
women who were foreign-born, obese, and smoked in
the last 3 months of pregnancy. The prevalence estimate
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by BMI was observed. Underweight women had a preva-
lence of 7.4% while obese women had a prevalence of
20.8%. A higher estimate of GDM was also noted in
smokers (15.8%) versus non-smokers (11.1%). Hawaiian/
Pacific Islander women, Filipinas, and other Asians all
had increased odds of GDM compared to white women
when compared using bivariate analysis (Table 2). After
adjusting for obesity, age, and maternal nativity, API
women had a 50% increased odds of GDM compared to
white women (aOR 1.49, CI 1.05-2.11).
Estimates of GDM with associated macrosomia by eth-
nicity are shown in Figure 1. Among women with GDM,
the highest prevalence of macrosomia was in white
women (14.5%) while the lowest was in Filipina women
(5.3%). The association between ethnicity and macrosomia
in women with GDM was examined using bivariate analysis
(Table 3). A trend towards increased odds of macrosomia
and GDM compared to women without GDM was noted
in all ethnic groups. These findings were not statistically
significant and due to limited cases of macrosomia in
women with GDM, multivariate analysis was unable to be
performed.
Discussion
In Hawaii, API women have higher rates of GDM com-
pared to white women. The overall GDM prevalence
(10.9%) in Hawaii was higher compared to the national
estimate (7%) [1], but the prevalence in API women
(12.1%) was consistent with those reported in other parts
of the country. Birth certificate data from California
noted GDM prevalence to be 10% among Asian women,
[14] while birth certificate data from Florida showed a
GDM prevalence of 9.9% among API women [22]. Data
from Oregon PRAMS observed that API had a GDM
prevalence rate of 14.8% [17]. Thus, our data was con-
sistent with previously published work.Figure 1 Prevalence (%) of GDM and associated macrosomia by ethnOne reason for the ethnic variation in GDM rates may
be imperfect screening and a diagnostic process that
over identifies glucose intolerance in certain racial/eth-
nic groups. GDM in the United States is generally diag-
nosed in a two-step process, although a one-step process
has been suggested and is controversial. The two-step
process includes a one-hour 50-gram glucose loading
test (GLT) administered first. If the GLT test is above a
certain threshold level, patients are then referred for a
three-hour 100-gram glucose tolerance test (GTT).
Diagnosis of GDM is made when two out of four values
on the GTT are above a set threshold. Race-specific
thresholds of these tests have been suggested in previous
studies. For example, Nahum et al. [23] demonstrated
that mean GLT values vary significantly by race. They
found that Black women had the lowest mean GLT value
(116.4 mg/dL) while Asian women had the highest
(134.7 mg/dL). In this study, Asian women had the
highest proportion (40.6%) exceeding the 140-mg/dL
threshold, but the lowest proportion (11.5%) of positive
GTT for women with the screening results greater than
140 mg/dL. Esakoff et al. [24] also showed different GLT
test characteristics among different racial/ethnic groups.
They found that to achieve 90% sensitivity and 10%
false-positive rate, the optimal screening threshold was
135 mg/dL for Blacks, 140 mg/dL for whites and
Latinas, and 145 mg/dL for Asians. Koklanaris et al. [25]
cautioned against raising the screening threshold to
150 mg/dL for Asian women given the risk for the
under-diagnosis of GDM. In their study of 95 Asian
women with a GLT of 140–150 mg/dL, eight women
(11.9%) were diagnosed with GDM. Although the
authors found no differences in birth weight between
the cases and controls (Asian women with GLT less than
140 mg/dL), they had concerns that raising the GLT
threshold in Asian women may unacceptably lower
sensitivity of the test. Ferrara et al. [26] examined theicity.
Table 3 Macrosomia (Birth weight > 4000 g) among women with GDM compared to those without GDM
GDM N (%) No GDM N (%) Bivariate OR
Maternal ethnicity
White 136 (14.5) 1458 (12.5) 1.19 (0.48-2.96)
Hawaiian/Pacific Islandera 280 (11.4) 1397 (7.8) 1.52 (0.84-2.75)
Filipina 67 (5.3) 145 (1.7) 3.18 (0.80-12.65)
Other Asiansb 54 (5.4) 251 (3.1) 1.78 (0.43-7.35)
Asian and Pacific Islanderc 401 (8.5) 1792 (5.2) 1.69 (1.02-2.80)
aIncludes Samoan, Guamanian, Other Pacific Islanders.
bIncludes Japanese, Chinese, Korean, Vietnamese, Asian Indian, and other Asians.
cIncludes Hawaiians, Other Pacific Islanders, Filipinos, and Other Asians.
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the diagnostic thresholds used, the relationship of the
GDM prevalence by ethnicity was similar. They com-
pared two different GTT threshold cut-offs and found
that although the overall GDM prevalence rate de-
creased with the use of one of them, Asian women still
had the highest prevalence rate compared to other eth-
nicities. However, they failed to address whether the
GTT thresholds should vary by ethnicity.
Not only does GDM prevalence differ by ethnicity, the
interaction with obesity appears also to be affected by
ethnicity. In a retrospective study using linked birth cer-
tificate and maternal hospital discharge data for live,
singleton deliveries in Florida, ethnic differences in
GDM were found to be attributable to being overweight
and obese [22]. Only 15.1% of API GDM cases were at-
tributable to being overweight and obese compared to
41.2% among non-Hispanic whites [22]. A similar retro-
spective study in California used a large managed care
network and found that Asian and Filipina women had
higher rates of GDM (9.9% and 8.5%, respectively) at a
BMI of 22.0 to 24.9 kg/m2 compared to white, Black,
and Hispanic women [27]. API women seem to be at
risk of GDM at a lower BMI cut-off, but the association
between GDM and obesity may not be as clear com-
pared to that in other racial/ethnic groups.
In our study, the highest prevalence of macrosomia
among women with GDM was in white women (14.5%)
while the lowest was in Filipina women (5.3%). Women
in all racial/ethnic groups had a trend towards increased
odds of macrosomia in the presence of GDM compared
to those without GDM. However, these findings did not
reach statistical significance; likely due to the limited
number of macrosomic cases for women with GDM.
Lower rates of macrosomia in Asian women with GDM
have been noted in previous studies. When examining
racial differences in perinatal outcomes among women
with GDM, Nguyen et al. [14] noted Asian women had
lower odds of macrosomia compared to white, Black, or
Hispanic women. Esakoff et al. [19] also noted decreased
risk of macrosomia in Asian women with GDMcompared to white women. In a hospital-based cohort of
women with GDM, neonates born to Hawaiian/Pacific
Islander and Filipino women had an increased preva-
lence of macrosomia compared to neonates of Japanese,
Chinese, Caucasian women [20]. The racial/ethnic
differences in macrosomia rates may be due to the inclu-
sion of ethnicities in which a different definition of
macrosomia should be applied. Generally, macrosomia is
defined as birth weight greater than 4000 to 4500 grams
or greater than 90th percentile. While this may be ap-
propriate in homogeneous populations, it does not take
into account physiologic variations among racial/ethnic
groups that constitute populations within Hawaii. Many
experts suggest using ethnicity-specific large-for-gesta-
tional age (LGA), defined as greater than the 90th per-
centile of birth weight within a particular race/ethnicity,
which may be more appropriate for identifying high-risk
infants. When surveying developing countries around
the world, the World Health Organization (WHO) noted
lower rates of macrosomia (birth weight greater than
4000 grams) in Asian countries, such as the Philippines
(1.1%), India (0.5%), and Thailand (2.2%), compared to
14.9% in Algeria [28]. The cut-offs for 90th percentile
birth weights were also lower in the Philippines (3485
grams), India (3250 grams), and Thailand (3630 grams)
compared to a cut-off of 4050 grams in Algeria [28].
Even among macrosomic infants, there are racial/ethnic
disparities in perinatal complications. In a study from
New Zealand, infants with birth weights greater than
4500 grams born to Asian mothers were compared to
those born to Polynesian mothers [29]. The infants born
to Asian mothers were more likely to be admitted to the
neonatal intensive care unit, require intravenous dex-
trose, and have respiratory distress. To address this
issue, countries such as the UK, Canada, New Zealand,
and Australia have adopted the use of customized
growth curves which account for maternal ethnicity to
identify high-risk babies [30-35]. A study conducted in
Canada found that approximately 61 per 1000 male and
57 per 1000 female LGA newborns of South Asian des-
cent would be missed if conventional rather than
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a prospective study in New Zealand and Australia, the
use of customized birth weight curves showed a stronger
association with adverse outcomes compared to conven-
tional birth weight curves [35]. In ethnically diverse re-
gions in the U.S., such as Hawaii, the use of customized,
ethnicity-specific growth curves should be implemented
to correctly identify at-risk infants of GDM mothers.
Our study’s sample was a strength, representing all live
births in Hawaii. However, this study is not without
limitations. One such limitation is that Hawaii PRAMS
survey data is self-reported, and consequently subject to
bias due to recall or reporting factors. Additionally, the
self-reported data do not allow for confirmation of the
clinical diagnosis of GDM, or for further analysis of clin-
ical data such as degree of glycemic control, lifestyle
modification, and medication compliance. Another limi-
tation was the need to collapse multiple ethnic groups
into four larger groups due to small numbers. For ex-
ample, the Other Asian women group includes diverse
groups of people such as Chinese, Filipino, Laotian,
Hmong, Korean, Japanese, and Vietnamese, into a single
large group. We recognize the diversity within all of the
racial/ethnic groups in our study. Unfortunately, aggre-
gation was done to overcome limited sample size in our
study. Also, as a result of the OHSM race algorithm
used in Hawaii, API women in our sample could not be
identified as mixed race/ethnicity. Finally, our unique
population in Hawaii may not be generalizable to other
populations given the high numbers of women of mixed
race and ethnicity.Conclusions
Similar to other regions of the country, Asian and Pacific
Islander women in Hawaii have increased rates of GDM
compared to white women. Paradoxically, this elevated
GDM risk in API women was not associated with in-
creased rates of macrosomia. This suggests that the rela-
tionship between GDM and macrosomia is probably
more complex than generally appreciated, and that a re-
definition of “macrosomia” should be considered. Thus,
the use of customized growth curves to identify LGA in-
fants may be more appropriate in an ethnically diverse
population such as that of Hawaii. Further research on
ethnicity-specific diagnosis in GDM and macrosomia is
needed. More importantly, interpreting the associations
between these conditions and perinatal complications
among diverse populations will be a vital step towards
improving pregnancy outcomes.
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